Page last updated: 2024-08-25

16-bromoepiandrosterone and HIV Coinfection

16-bromoepiandrosterone has been researched along with HIV Coinfection in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dowding, C; Frincke, J; Garsd, A; Onizuka-Handa, N; Reading, C; Schramm, B; Stickney, D1

Trials

1 trial(s) available for 16-bromoepiandrosterone and HIV Coinfection

ArticleYear
Improvement in immune parameters and human immunodeficiency virus-1 viral response in individuals treated with 16alpha-bromoepiandrosterone (HE2000).
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2006, Volume: 12, Issue:11

    Topics: Adult; Androsterone; Anti-HIV Agents; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Cell Count; Cyclooxygenase 2; Dendritic Cells; Double-Blind Method; Female; Flow Cytometry; HIV Infections; HIV-1; Humans; Injections, Subcutaneous; Interleukin-1; Interleukin-2 Receptor alpha Subunit; Interleukin-6; Killer Cells, Natural; Lectins, C-Type; Leukocyte Count; Leukocytes, Mononuclear; Male; Membrane Proteins; Reagent Kits, Diagnostic; RNA, Messenger; T-Lymphocytes; Treatment Outcome; Tumor Necrosis Factor-alpha; Viral Load

2006